Kyongbo Pharmaceutical Co Ltd (214390) - Total Liabilities

Latest as of September 2025: ₩171.21 Billion KRW ≈ $116.03 Million USD

Based on the latest financial reports, Kyongbo Pharmaceutical Co Ltd (214390) has total liabilities worth ₩171.21 Billion KRW (≈ $116.03 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 214390 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Kyongbo Pharmaceutical Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Kyongbo Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Kyongbo Pharmaceutical Co Ltd (214390) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Kyongbo Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Kyongbo Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Terracom Ltd AU:TER	Australia	AU$161.47 Million
Groupe Minoteries SA SW:GMI	Switzerland	CHF45.97 Million
BIMobject AB ST:BIM	Sweden	Skr110.19 Million
Cullman Bancorp Inc. NASDAQ:CULL	USA	$367.78 Million
Dana Brata Luhur PT JK:TEBE	Indonesia	Rp63.74 Billion
Ten Ren Tea Co Ltd TW:1233	Taiwan	NT$843.20 Million
Kyungdong City Gas Co Ltd KO:267290	Korea	₩453.62 Billion
Aditya Birla Money Limited NSE:BIRLAMONEY	India	Rs31.66 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Kyongbo Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 214390 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.54	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kyongbo Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kyongbo Pharmaceutical Co Ltd (2014–2024)

The table below shows the annual total liabilities of Kyongbo Pharmaceutical Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩137.73 Billion ≈ $93.34 Million	+12.97%
2023-12-31	₩121.92 Billion ≈ $82.63 Million	+25.90%
2022-12-31	₩96.84 Billion ≈ $65.63 Million	+6.09%
2021-12-31	₩91.28 Billion ≈ $61.86 Million	-6.08%
2020-12-31	₩97.18 Billion ≈ $65.86 Million	+9.62%
2019-12-31	₩88.65 Billion ≈ $60.08 Million	+22.09%
2018-12-31	₩72.61 Billion ≈ $49.21 Million	+14.60%
2017-12-31	₩63.36 Billion ≈ $42.94 Million	-14.76%
2016-12-31	₩74.33 Billion ≈ $50.37 Million	+2.29%
2015-12-31	₩72.67 Billion ≈ $49.25 Million	-27.11%
2014-12-31	₩99.70 Billion ≈ $67.57 Million	--

About Kyongbo Pharmaceutical Co Ltd

KO:214390 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$82.46 Million

₩121.69 Billion KRW

Market Cap Rank

#19813 Global

#989 in Korea

Share Price

₩5090.00

Change (1 day)

+1.60%

52-Week Range

₩4825.00 - ₩8550.00

All Time High

₩19100.23